Similar articles for PMID: 28965748

Year	Number of Results
1999	1
2001	1
2002	2
2003	1
2004	4
2005	1
2006	2
2007	1
2008	5
2009	1
2010	4
2011	5
2012	6
2013	10
2014	6
2015	11
2016	11
2017	20
2018	8
2019	7
2020	3
2021	6
2022	3
2023	1
2024	0

1

The Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Adult Patients with Type 2 Diabetes: The Multicentre Randomized Controlled R_xEACH Trial.

Al Hamarneh YN, Hemmelgarn BR, Hassan I, Jones CA, Tsuyuki RT. Al Hamarneh YN, et al. Can J Diabetes. 2017 Dec;41(6):580-586. doi: 10.1016/j.jcjd.2017.08.244. Epub 2017 Sep 28. Can J Diabetes. 2017. PMID: 28965748 Clinical Trial.

2

Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Patients With CKD: A Subgroup Analysis of the Randomized Controlled R_xEACH Trial.

Al Hamarneh YN, Tsuyuki RT, Jones CA, Manns B, Tonelli M, Scott-Douglass N, Jindal K, Tink W, Hemmelgarn BR. Al Hamarneh YN, et al. Am J Kidney Dis. 2018 Jan;71(1):42-51. doi: 10.1053/j.ajkd.2017.07.012. Epub 2017 Sep 12. Am J Kidney Dis. 2018. PMID: 28912054 Clinical Trial.

3

The Effectiveness of Pharmacist Interventions on Cardiovascular Risk: The Multicenter Randomized Controlled RxEACH Trial.

Tsuyuki RT, Al Hamarneh YN, Jones CA, Hemmelgarn BR. Tsuyuki RT, et al. J Am Coll Cardiol. 2016 Jun 21;67(24):2846-54. doi: 10.1016/j.jacc.2016.03.528. Epub 2016 Apr 4. J Am Coll Cardiol. 2016. PMID: 27058907 Free article. Clinical Trial.

4

Efficacy of a telephone-based intervention among patients with type-2 diabetes; a randomized controlled trial in pharmacy practice.

Sarayani A, Mashayekhi M, Nosrati M, Jahangard-Rafsanjani Z, Javadi M, Saadat N, Najafi S, Gholami K. Sarayani A, et al. Int J Clin Pharm. 2018 Apr;40(2):345-353. doi: 10.1007/s11096-018-0593-0. Epub 2018 Feb 12. Int J Clin Pharm. 2018. PMID: 29435911 Clinical Trial.

5

A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.

Yu J, Shah BM, Ip EJ, Chan J. Yu J, et al. J Manag Care Pharm. 2013 Mar;19(2):102-14. doi: 10.18553/jmcp.2013.19.2.102. J Manag Care Pharm. 2013. PMID: 23461426 Free PMC article.

6

Effectiveness of Dader Method for pharmaceutical care on control of blood pressure and total cholesterol in outpatients with cardiovascular disease or cardiovascular risk: EMDADER-CV randomized controlled trial.

Amariles P, Sabater-Hernández D, García-Jiménez E, Rodríguez-Chamorro MÁ, Prats-Más R, Marín-Magán F, Galán-Ceballos JA, Jiménez-Martín J, Faus MJ. Amariles P, et al. J Manag Care Pharm. 2012 May;18(4):311-23. doi: 10.18553/jmcp.2012.18.4.311. J Manag Care Pharm. 2012. PMID: 22548691 Free PMC article. Clinical Trial.

7

Effects of Pharmacy-Based Interventions on the Control and Management of Diabetes in Adults: A Systematic Review and Meta-Analysis.

Yaghoubi M, Mansell K, Vatanparastc H, Steeves M, Zeng W, Farag M. Yaghoubi M, et al. Can J Diabetes. 2017 Dec;41(6):628-641. doi: 10.1016/j.jcjd.2017.09.014. Can J Diabetes. 2017. PMID: 29224636 Review.

8

Community Pharmacists Assisting in Total Cardiovascular Health (CPATCH): A Cluster-Randomized, Controlled Trial Testing a Focused Adherence Strategy Involving Community Pharmacies.

Blackburn DF, Evans CD, Eurich DT, Mansell KD, Jorgenson DJ, Taylor JG, Semchuk WM, Shevchuk YM, Remillard AJ, Tran DA, Champagne AP. Blackburn DF, et al. Pharmacotherapy. 2016 Oct;36(10):1055-1064. doi: 10.1002/phar.1831. Epub 2016 Sep 25. Pharmacotherapy. 2016. PMID: 27581815 Clinical Trial.

9

A Cost Analysis and Cost-Utility Analysis of a Community Pharmacist-Led Intervention on Reducing Cardiovascular Risk: The Alberta Vascular Risk Reduction Community Pharmacy Project (R_xEACH).

Tam-Tham H, Clement F, Hemmelgarn BR, Manns BJ, Klarenbach SW, Tonelli M, Tsuyuki RT, Al Hamarneh YN, Penko J, Weaver CGW, Au F, Weaver RG, Jones CA, McBrien KA. Tam-Tham H, et al. Value Health. 2019 Oct;22(10):1128-1136. doi: 10.1016/j.jval.2019.05.012. Epub 2019 Aug 17. Value Health. 2019. PMID: 31563255 Free article.

10

Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).

Houle SK, Chuck AW, McAlister FA, Tsuyuki RT. Houle SK, et al. Pharmacotherapy. 2012 Jun;32(6):527-37. doi: 10.1002/j.1875-9114.2012.01097.x. Epub 2012 May 2. Pharmacotherapy. 2012. PMID: 22552863 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

106 results

Results by year